COL1A2 and atherosclerosis: The parameters indicating AA and atherosclerosis progression were detected in Col1a2+/G610C.ApoE-/- mice with AngII infusion, after administration of humanized therapeutic sclerostin antibody (Hongmed-Infagen/Creative Biolabs, 25 mg/kg, twice per week) for four weeks.